I fully expect, and I will not try to stop a biosimilar IV version of KEYTRUDA coming on to the marketplace.
Ben Ray Luján: “I fully expect, and I will not try to stop a biosimilar IV version of KEYTRUDA coming on to the marketplace.”
On the recordFebruary 8, 2024
Source
congress.govEditor's note · Context
Lujan expresses expectation for biosimilar market entry post-patent expiration.
Share
More from Ben Ray Luján
Aug 9, 2026
The Attorney General’s duty is to uphold the rule of law, defend the Constitution, and ensure that justice is applied fairly and equally to every American.
Aug 12, 2026
In Albuquerque, I was honored to visit the Rotary Club and UNMH to hear from leaders and highlight how I am fighting for New Mexicans in Washington, D.C.
Aug 28, 2026
If ICE proceeds with purchasing $20 million worth of electric-shock gloves, Congress needs a clear understanding of the device’s safety and authorized uses.
Aug 9, 2026
Critically, it also prevents Trump from further politicizing and disrupting federal grants that communities across New Mexico rely on.





